Imatib - Imatinib
Imatib Imatinib belongs to a class of
medications known as protein-tyrosine kinase inhibitor. Imatib is suitably
recommended in the treatment of leukemia (chronic myeloid leukemia or CML)
and gastrointestinal stromal tumors. After the proper surgical removal of
GIST, this range ensures to avoid the cancer cells that might develop in
patient's body. In case, when dermatofibrosarcoma protuberans (a tumor that
forms under the top layer of skin) cannot be cured with surgical operations,
Imatib drugs is recommended by the physicians for curing the same.
Imatib is used for the treatment of a type of leukemia (chronic myeloid
leukemia or CML), gastrointestinal stromal tumors (GISTs - a type of tumor
that grows in the walls of the digestive passages and may spread to other
parts of the body). Imatib may be used to prevent cancer from growing in
patients after surgical removal of GIST. Imatib is also used for the
treatment of dermatofibrosarcoma protuberans (a tumor that forms under the
top layer of skin) when the tumor cannot be removed surgically, has spread
to other parts of the body, or has come back after surgery. Imatib is also
used to treat mastocytosis (a buildup of large amounts of mast cells in
certain parts of the body).
100 mg & 400 mg tablets.
Cipla Ltd. (INDIA)
Imatib is a prescription drug and should be used under proper medical
guidance and advice.